FdaApplication

ANDA 215724

Back to search

Identifiers

Properties

PropertyValue
applicant_nameRUBICON RESEARCH LTD
application_typeANDA
approval_date2022-08-18

Products (1)

ProductActive ingredientStrengthDosage form
ACYCLOVIRACYCLOVIR200MG/5MLSUSPENSION;ORAL

1 product